Digital subsidiary launched by global pet health groupFebruary 22, 2021Boehringer Ingelheim Animal Health USA has established Pawru, Inc., as a separate company within the Boehringer Ingelheim Animal Health business.
Education Center - SponsoredAlternative therapies for improving quality of life in senior petsby • VetriScience Pro LineAdvances in veterinary medicine and animal nutrition have resulted in pets living longer than ever before. That leaves an increasing number of cats and dogs prone to common age-related problems.
Industry giant invests in K-State, animal health hubNovember 19, 2020Preparing the next generation of veterinarians for the evolving role of the profession is the driving force behind a new strategic collaboration.
Vaccine bait aims to control rabies in U.S. wildlifeSeptember 3, 2020Protecting America’s heartland from a deadly, preventable disease is the goal of a U.S. Department of Agriculture (USDA) program currently underway in the country’s northeast region.
Boehringer declares war on wormsFebruary 18, 2020Following the success of its Heartworm 2020 initiative, which saw 58,800 previously unprotected dogs receive heartworm disease prevention, Boehringer Ingelheim has upped the ante for 2021.
Boehringer invests $50M in Puerto Rico facilityNovember 25, 2019Boehringer Ingelheim has expanded the production capacity of its manufacturing site in Barceloneta, P.R., with a $50-million investment.
Boehringer streamlines NGS through partnershipNovember 14, 2019An enhanced partnership between Boehringer Ingelheim and biopharmaceutical research and development (R&D) provider, Genedata, is set to automate the pharmaceutical company’s complex cell line development processes.
Heartworm initiative sees 51,000 dogs protectedNovember 8, 2019More than 51,000 previous unprotected dogs are now receiving heartworm disease prevention, thanks to a nationwide initiative from Boehringer Ingelheim.
Boehringer Ingelheim completes $76-million expansionOctober 14, 2019Boehringer Ingelheim revealed a $76-million expansion at its manufacturing plant in Athens, Ga., that will double the company’s capacity to produce vaccines for pets.
